DIRECT DIGITAL HOLDINGS IN-A (DRCT) Stock Fundamental Analysis
USA - NASDAQ:DRCT - US25461T1051 - Common Stock
0.42 USD
+0.01 (+1.47%)
0.4193 USD
0 (-0.17%)
DRCT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 99 industry peers in the Media industry. DRCT may be in some trouble as it scores bad on both profitability and health. DRCT is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year DRCT has reported negative net income.
DRCT had a negative operating cash flow in the past year.
DRCT had negative earnings in 4 of the past 5 years.
In multiple years DRCT reported negative operating cash flow during the last 5 years.
1.2 Ratios
DRCT has a Return On Assets of -40.62%. This is amonst the worse of the industry: DRCT underperforms 80.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -40.62% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-6.66%
ROA(5y)-5.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DRCT's Gross Margin of 34.05% is in line compared to the rest of the industry. DRCT outperforms 43.43% of its industry peers.
In the last couple of years the Gross Margin of DRCT has declined.
The Profit Margin and Operating Margin are not available for DRCT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 34.05% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.71%
GM growth 5YN/A
2. Health
2.1 Basic Checks
DRCT does not have a ROIC to compare to the WACC, probably because it is not profitable.
DRCT has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, DRCT has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -1.51, we must say that DRCT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.51, DRCT is not doing good in the industry: 75.76% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.51 |
ROIC/WACCN/A
WACC11.56%
2.3 Liquidity
A Current Ratio of 0.49 indicates that DRCT may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.49, DRCT is doing worse than 84.85% of the companies in the same industry.
DRCT has a Quick Ratio of 0.49. This is a bad value and indicates that DRCT is not financially healthy enough and could expect problems in meeting its short term obligations.
DRCT's Quick ratio of 0.49 is on the low side compared to the rest of the industry. DRCT is outperformed by 84.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.49 | ||
| Quick Ratio | 0.49 |
3. Growth
3.1 Past
DRCT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2208.27%.
The Revenue for DRCT has decreased by -74.79% in the past year. This is quite bad
Measured over the past years, DRCT shows a quite strong growth in Revenue. The Revenue has been growing by 17.76% on average per year.
EPS 1Y (TTM)-2208.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.75%
Revenue 1Y (TTM)-74.79%
Revenue growth 3Y17.76%
Revenue growth 5YN/A
Sales Q2Q%-53.58%
3.2 Future
The Earnings Per Share is expected to grow by 40.03% on average over the next years. This is a very strong growth
DRCT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 20.00% yearly.
EPS Next Y87.74%
EPS Next 2Y40.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.44%
Revenue Next 2Y20%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
DRCT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year DRCT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as DRCT's earnings are expected to grow with 40.03% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.03%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for DRCT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
0.42
+0.01 (+1.47%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)
Earnings (Next)
Inst Owners3.46%
Inst Owner Change47.21%
Ins Owners5.17%
Ins Owner Change16.87%
Market Cap9.48M
Analysts80
Price Target6.12 (1357.14%)
Short Float %3.26%
Short Ratio0.93
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3354.62%
Min EPS beat(2)-6762.75%
Max EPS beat(2)53.51%
EPS beat(4)1
Avg EPS beat(4)-2084.79%
Min EPS beat(4)-6762.75%
Max EPS beat(4)53.51%
EPS beat(8)2
Avg EPS beat(8)-1048.56%
EPS beat(12)3
Avg EPS beat(12)-707.85%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.43%
Min Revenue beat(2)-15.98%
Max Revenue beat(2)-14.88%
Revenue beat(4)0
Avg Revenue beat(4)-37.87%
Min Revenue beat(4)-85.1%
Max Revenue beat(4)-14.88%
Revenue beat(8)1
Avg Revenue beat(8)-22.07%
Revenue beat(12)5
Avg Revenue beat(12)-7.76%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-108.82%
EPS NQ rev (3m)-121.43%
EPS NY rev (1m)45.67%
EPS NY rev (3m)-297.14%
Revenue NQ rev (1m)-36.16%
Revenue NQ rev (3m)-20.89%
Revenue NY rev (1m)-22.49%
Revenue NY rev (3m)-23.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.26 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-3.07
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS1.62
BVpS-0.47
TBVpS-1.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -40.62% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 34.05% | ||
| FCFM | N/A |
ROA(3y)-6.66%
ROA(5y)-5.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.71%
GM growth 5YN/A
F-Score2
Asset Turnover1.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 1.87% | ||
| Cap/Sales | 0.12% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.49 | ||
| Quick Ratio | 0.49 | ||
| Altman-Z | -1.51 |
F-Score2
WACC11.56%
ROIC/WACCN/A
Cap/Depr(3y)14.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.3%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2208.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.75%
EPS Next Y87.74%
EPS Next 2Y40.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-74.79%
Revenue growth 3Y17.76%
Revenue growth 5YN/A
Sales Q2Q%-53.58%
Revenue Next Year6.44%
Revenue Next 2Y20%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-60.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year103.23%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-190.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-175.09%
OCF growth 3YN/A
OCF growth 5YN/A